These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 323546)

  • 1. [Artificial pancreatic beta cells --present status and future].
    Shigeta Y; Shichiri M
    Nihon Rinsho; 1977 Feb; 35(2):337-42. PubMed ID: 323546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of diabetes and the artificial endocrine pancreas].
    Albisser AM; Leibel BS; Marliss EB; Zinman B; Botz CK; Zingg W; Murray FT; Denoga A
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():259-68. PubMed ID: 796523
    [No Abstract]   [Full Text] [Related]  

  • 3. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapy of diabetes.
    Maurer AC
    Am Sci; 1979; 67(4):422-31. PubMed ID: 119452
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Artificial pancreatic beta cells--the present status and prospect].
    Shichiri M; Kawamori T; Goriya Y; Shigeta Y
    Nihon Rinsho; 1976 Sep; 34(9):2886-93. PubMed ID: 792496
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood glucose regulation in the depancreatized dogs by the artificial beta cell (author's transl)].
    Kawamori R; Goriya Y; Yamasaki Y; Shichiri M; Abe H
    Iyodenshi To Seitai Kogaku; 1978 Apr; 16(2):81-8. PubMed ID: 691860
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Future aspects in diabetology].
    Pfeiffer EF
    Internist (Berl); 1981 Apr; 22(4):229-41. PubMed ID: 7014511
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W; Beischer W; Herfarth C; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Artificial pancreas].
    Yamada A
    Nihon Rinsho; 1980; 38(1):217-26. PubMed ID: 6993724
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutical application of artificial beta-cell in surgery and obstetrics.
    Brunetti P; Puxeddu A; Calabrese G; Massi-Benedetti M; Santeusanio F; Bolli G; Scionti L; Bueti A; Angeletti G
    Horm Metab Res Suppl; 1979; (8):162-5. PubMed ID: 395074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.